| Current Price | $73.61 | Mkt Cap | $186.3B |
|---|---|---|---|
| Open | $73.59 | P/E Ratio | 33.44 |
| Prev. Close | $73.61 | Div. (Yield) | $2.60 (3.5%) |
| Daily Range | $73.35 - $74.63 | Volume | 14,714,660 |
| 52-Wk Range | $68.38 - $85.60 | Avg. Daily Vol. | 10,670,659 |
A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.
| Current Price | $73.61 | Mkt Cap | $186.3B |
|---|---|---|---|
| Open | $73.59 | P/E Ratio | 33.44 |
| Prev. Close | $73.61 | Div. (Yield) | $2.60 (3.5%) |
| Daily Range | $73.35 - $74.63 | Volume | 14,714,660 |
| 52-Wk Range | $68.38 - $85.60 | Avg. Daily Vol. | 10,670,659 |
The best Bull and Bear pitches based on recency and number of recommendations.
Terrible leadership + atrocious decision making has fostered a culture of fear and indifference. Not sure how that bolsters the pipeline.
Read the most recent pitches from players about MRK.
Recs
TMFbonefish
(61.85)
Submitted: 9/7/2021 5:33:22 PM :
Start Price:
$75.97
NYSE:MRK Score:
-1.65
Spinning off slow-growth business is a good start. I think it will sell animal health to unlock value there. Keytruda keeps performing well. In an expensive market, this dividend payer will weather any downturn.
Recs
TMFkodyk123
(31.56)
Submitted: 8/18/2021 3:36:39 PM :
Start Price:
$77.98
NYSE:MRK Score:
-6.27
While Keytruda will drive the bulk of Merck's growth in the next five years, the company also boasts vaccine and animal health businesses that should benefit from strong industry growth. With a PEG ratio of just 1.1, Merck also trades at a reasonable price for the long-term.
Recs
quinpeung
(64.30)
Submitted: 1/18/2021 6:17:37 PM :
Start Price:
$80.44
NYSE:MRK Score:
-25.94
Symmetrical triangle pattern, poised for breakout...
Find the members with the highest scoring picks in MRK.
TrackTobinSmith (< 20) Score: +174.33
The Score Leader is the player with the highest score across all their picks in MRK.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| kaliblade | 82.98 | 2/12/2009 |
|
3W | $18.92 | +289.20% | +450.65% | +161.45 | 0 Comment | |
| JoeySly | 91.81 | 3/6/2009 |
|
3W | $14.71 | +400.82% | +551.87% | +151.05 | 0 Comment | |
| prettymeadow | < 20 | 3/20/2009 |
|
3M | $17.51 | +320.64% | +470.27% | +149.63 | 0 Comment | |
| fordfest99 | 39.32 | 3/26/2009 |
|
3Y | $18.18 | +305.11% | +441.95% | +136.84 | 0 Comment | |
| buckywildcat | < 20 | 1/26/2009 |
|
1Y | $18.17 | +305.29% | +441.16% | +135.88 | 0 Comment | |
| JR119 | < 20 | 3/10/2009 |
|
5Y | $14.26 | +416.53% | +550.78% | +134.25 | 1 Comment | |
| stockpickeraz | 25.98 | 1/16/2009 |
|
5Y | $18.29 | +302.66% | +435.25% | +132.58 | 0 Comment | |
| MikeylitoMKM | 61.02 | 4/3/2009 |
|
3M | $17.76 | +314.55% | +437.98% | +123.42 | 0 Comment | |
| niwhsa | 75.80 | 11/20/2008 |
|
3Y | $16.45 | +347.67% | +469.51% | +121.85 | 0 Comment | |
| dbwhiz57 | < 20 | 12/17/2007 |
|
1Y | $36.83 | +99.96% | +221.00% | +121.04 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
